Trademark: 97040324
Word
FORLIWU
Status
Pending
Status Code
732
Status Date
Friday, January 5, 2024
Serial Number
97040324
Mark Type
4000
Filing Date
Wednesday, September 22, 2021
Published for Opposition
Tuesday, May 24, 2022

Trademark Owner History
Incyte Holdings Corporation - Owner At Publication

Classifications
5 Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of hypophosphatemia disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders; pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders; pharmaceutical preparations for the treatment of dermatological disorders
16 Printed brochures, newsletters, and pamphlets in the fields of medical issues, procedures, disease symptoms, patient support and community building
44 Providing a medical information to healthcare providers and patients relating to viral, hematological, auto-immune, inflammatory, metabolic and dermatological disorders

Trademark Events
Jan 9, 2024
Notice Of Approval Of Extension Request E-Mailed
Jan 5, 2024
Sou Extension 3 Granted
Jan 5, 2024
Sou Extension 3 Filed
Jan 5, 2024
Sou Teas Extension Received
Jul 15, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 13, 2023
Sou Extension 2 Granted
Jul 13, 2023
Sou Extension 2 Filed
Jul 13, 2023
Sou Teas Extension Received
Jan 14, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 12, 2023
Sou Extension 1 Granted
Jan 12, 2023
Sou Extension 1 Filed
Jan 12, 2023
Sou Teas Extension Received
Jul 19, 2022
Noa E-Mailed - Sou Required From Applicant
May 24, 2022
Official Gazette Publication Confirmation E-Mailed
May 24, 2022
Published For Opposition
May 4, 2022
Notification Of Notice Of Publication E-Mailed
Apr 20, 2022
Approved For Pub - Principal Register
Apr 20, 2022
Examiner's Amendment Entered
Apr 20, 2022
Notification Of Examiners Amendment E-Mailed
Apr 20, 2022
Examiners Amendment E-Mailed
Apr 20, 2022
Examiners Amendment -Written
Apr 20, 2022
Assigned To Examiner
Oct 25, 2021
New Application Office Supplied Data Entered
Sep 25, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24